Prognostic and Predictive Biomarkers in Patients With Coronavirus Disease 2019 Treated With Tocilizumab in a Randomized Controlled Trial.

J, Tom; M, Bao; L, Tsai; A, Qamra; D, Summers; M, Carrasco-Triguero; J, McBride; CM, Rosenberger; CJF, Lin; W, Stubbings; KG, Blyth; J, Carratalà; B, François; T, Benfield; D, Haslem; P, Bonfanti; der Leest CH, van; N, Rohatgi; L, Wiese; CE, Luyt; F, Kheradmand; IO, Rosas; F, Cai

doi:10.1097/ccm.0000000000005229

Public

Prognostic and Predictive Biomarkers in Patients With Coronavirus Disease 2019 Treated With Tocilizumab in a Randomized Controlled Trial.

Shared by NobleBlocks on Mar 1, 2022 • 12:00 AM UTC

Authors:

Tom J

Bao M

Tsai L

Abstract

Objectives To explore candidate prognostic and predictive biomarkers identified in retrospective observational studies (interleukin-6, C-reactive protein, lactate dehydrogenase, ferritin, lymphocytes, monocytes, neutrophils, d-dimer, and platelets) in patients with coronavirus disease 2019 pneumonia...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!